Clinical Trial Update: Probiotic on Type 2 Diabetes and Chronic Obstruction Pulmonary Disease [NA]

View source ↗

Summary

A probiotic clinical trial investigating Type 2 diabetes mellitus and chronic obstructive pulmonary disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Probiotic (probiotic)

Snippet

Sponsor: Glac Biotech Co., Ltd | Conditions: Type 2 Diabetes, Chronic Obstructive Pulmonary Disease | NA | Status: TERMINATED